R. Yu

728 total citations
7 papers, 551 citations indexed

About

R. Yu is a scholar working on Molecular Biology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Yu has authored 7 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Dermatology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Yu's work include Skin Protection and Aging (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). R. Yu is often cited by papers focused on Skin Protection and Aging (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). R. Yu collaborates with scholars based in United States, Australia and Argentina. R. Yu's co-authors include Neil J. Gallagher, Ian W. Flinn, Timothy P. Hughes, Richard A. Larson, Mineo Kurokawa, Andreas Hochhaus, Gabriel Étienne, Eric F. Bernstein, Beatriz Moiraghi and Douglas B. Brown and has published in prestigious journals such as Journal of Clinical Oncology, Neuroscience and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R. Yu

7 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Yu United States	5	303	248	167	99	83	7	551
Martin Klein Czechia	14	44 0.1×	28 0.1×	137 0.8×	194 2.0×	28 0.3×	34	479
Claudia Cesaretti Italy	12	197 0.7×	235 0.9×	59 0.4×	61 0.6×	27 0.3×	34	504
Wanming Zhao United States	8	118 0.4×	198 0.8×	71 0.4×	210 2.1×	4 0.0×	9	384
María Antonia Durán Spain	9	145 0.5×	114 0.5×	36 0.2×	84 0.8×	4 0.0×	28	258
Steffen Pfeuffer Germany	15	46 0.2×	43 0.2×	79 0.5×	89 0.9×	6 0.1×	53	588
Y Takimoto Japan	11	97 0.3×	45 0.2×	26 0.2×	157 1.6×	16 0.2×	48	355
Erzsébet Balogh Hungary	12	96 0.3×	56 0.2×	24 0.1×	144 1.5×	17 0.2×	56	408
Masafumi Oka Japan	12	57 0.2×	25 0.1×	30 0.2×	141 1.4×	10 0.1×	38	331
Shari Fallet United States	12	22 0.1×	60 0.2×	110 0.7×	389 3.9×	34 0.4×	18	739
Qing Yue China	11	21 0.1×	49 0.2×	73 0.4×	107 1.1×	54 0.7×	16	426

Countries citing papers authored by R. Yu

Since Specialization

Citations

This map shows the geographic impact of R. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Yu more than expected).

Fields of papers citing papers by R. Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Yu. The network helps show where R. Yu may publish in the future.

Co-authorship network of co-authors of R. Yu

This figure shows the co-authorship network connecting the top 25 collaborators of R. Yu. A scholar is included among the top collaborators of R. Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Yu. R. Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Liu, Yan, Ye Chen, R. Yu, et al.. (2024). A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 120(2). e433–e434. 1 indexed citations

2.

Larson, Richard A., Andreas Hochhaus, Timothy P. Hughes, et al.. (2012). Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up. Leukemia. 26(10). 2197–2203. 323 indexed citations

3.

Weekes, Colin D., P. LoRusso, L-Y Shih, et al.. (2011). A phase Ib study for MNRP1685A (anti-NRP1) administered intravenously with bevacizumab with or without paclitaxel to patients with advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3050–3050. 11 indexed citations

4.

Patnaik, Amita, Colin D. Weekes, Priti S. Hegde, et al.. (2010). A phase Ib study to evaluate the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously in combination with bevacizumab with or without weekly paclitaxel in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). TPS180–TPS180. 2 indexed citations

5.

Xu, Jin, et al.. (2005). Identification and characterization of six new alternatively spliced variants of the human μ opioid receptor gene, Oprm. Neuroscience. 133(1). 209–220. 101 indexed citations

6.

Bernstein, Eric F., et al.. (2001). Glycolic Acid Treatment Increases Type I Collagen mRNA and Hyaluronic Acid Content of Human Skin. Dermatologic Surgery. 27(5). 429–433. 89 indexed citations

7.

Bernstein, Eric F., et al.. (2001). Glycolic Acid Treatment Increases Type I Collagen mRNA and Hyaluronic Acid Content of Human Skin. Dermatologic Surgery. 27(5). 429–433. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact